openPR Logo
Press release

Market Size of Genital Herpes Treatment, Forecast Report 2016-2026

07-26-2016 08:59 AM CET | Health & Medicine

Press release from: Future Market Insights

Market Size of Genital Herpes Treatment, Forecast Report

General herpes is a sexually transmitted infection (STI), caused by herpes simplex virus. It causes painful blisters on the genital organs and surrounding areas of both men and women. It also affects mucus membrane present in the body. Prevalence rate of genital herpes is high in women when compared with men. Genital herpes is a chronic condition and it is not having any cure, however, medication is available to reduce triggered symptoms of the disease. The viral infection is permanent in human body and will become active and causes painful blisters occasionally in first two years. The average rate of recurrence is five times in a first two years and the rate of recurrence will decrease in each time. Prevalence rate of this disease is high in population with age from 20 to 24 years. It also causes severe health problems in a pregnant women.

Treatment methods include initial treatment, intermittent treatment and suppressive treatment. Antiviral drugs are usually prescribed for seven to ten days in the initial treatment. In an intermittent therapy, treatment was prescribed depend on the symptoms patient such as cold sores. In a suppressive therapy, based on the symptoms patients has to take medication every day. Drugs include acyclovir, famciclovir, and valacyclovir are prescribed for genital herpes therapy and based on the condition drugs are given to patient orally and intravenously.

Genital Herpes Treatment Market: Drivers and Restraints

According to center for disease control and prevention approximately 50 million population affected with genital herpes in the U.S. Raising prevalence rate of herpes simplex virus, insecure sexual contacts are the major factors deriving the growth of genital herpes treatment market. Moreover, increasing awareness about sexually transmitted diseases and raising awareness about healthcare drives the genital herpes treatment market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1390

Genital Herpes Treatment Market: Segmentation

Genital Herpes Treatment Market is segmented into product type, distribution channel and region

Based on genital herpes product type, the global genital herpes treatment market is segmented into:

Acyclovir

Famciclovir

Valacyclovir

Based on genital herpes treatment distribution channel, the global genital herpes treatment market is segmented into:

Hospital Pharmacies

General Pharmacies

Drug stores

Genital Herpes Treatment Market: Overview

Increasing healthcare awareness among mass population along with rise in prevalence rate of genital herpes is expected to propel the overall demand for Genital Herpes Treatment worldwide. The market is expected to witness a healthy growth over the forecast period (2016-2026)

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1390

Genital Herpes Treatment Market: Region- wise Outlook

Depending on geographic regions, the global genital herpes treatment market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa. North America is expected to be the most dominant region for genital herpes treatment during the forecast period, owing strong healthcare setup and people having good awareness about STI diseases. However, Asia Pacific region is expected to expand at remarkable CAGR in genital herpes treatment market due to increasing healthcare awareness and favorable policies implemented by the government to start-up companies.

Genital Herpes Treatment Market: Key Players

Some of the key players in this market are Teva Pharmaceuticals Inc., GlaxoSmithKline, Ranbaxy Laboratories Ltd., Mylan Pharmaceuticals Inc., Hospira Inc., Apotheca Inc., Novartis AG, Novopharm Ltd., Dr Reddys Laboratories Ltd., Sandoz Inc. and others.

Browse Full Report@ http://www.futuremarketinsights.com/reports/genital-herpes-treatment-market

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Market Size of Genital Herpes Treatment, Forecast Report 2016-2026 here

News-ID: 351650 • Views:

More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,

All 5 Releases


More Releases for Genital

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Rising Sexual Health Awareness To Drive Genital Herpes Market Growth: A Key Driv …
The Genital Herpes Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Genital Herpes Market Size and Its Estimated Growth Rate? The genital herpes market has experienced strong growth in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion
Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts …
The Genital Warts Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Genital Warts Market Size and Projected Growth Rate? The genital warts market has grown strongly in recent years. It is set to increase from $1.97 billion in 2024 to $2.08 billion in
Genital Warts Market - Revolutionizing Intimate Care: Transforming the Genital W …
Newark, New Castle, USA: The "Genital Warts Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Genital Warts Market: https://www.growthplusreports.com/report/genital-warts-market/8677 This latest report researches the industry structure, sales, revenue,
Genital Herpes - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Genital Herpes - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H1 2017, provides an overview of the Genital Herpes (Infectious Disease) pipeline landscape. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused
Genital Herpes - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thyroid Cancer - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer – Pipeline Review, H1 2017, provides an overview of the Thyroid Cancer (Oncology) pipeline landscape. Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include lump that can be felt through